Legal Professional?
Build Your Business
Drop to LL.com Full View
Facebook Icon Twitter Icon

Talk to a Lawyer Today

Topamax Drug Recall Lawsuit - Defective Drug Lawyer & Product Liability Attorney



Injured parties who took Topamax might have already filed medical malpractice, product liability and/or other types of personal injury lawsuits to seek compensation for their injuries purportedly caused by the medication. Alternatively, those parties could be in the introductory process of collecting and gathering information, meeting with counsel and exploring whether to file suit. It is important to consult with a Topamax drug recall attorney as soon as possible to best preserve any claims and their highest possible values. Issues such as the time allotted for filing suit, the correct parties to sue, proper parties to file suit, best medical treatment and diagnosis, damages and compensation can be addressed by counsel familiar with Topamax, these injuries and the resulting litigation.

What Is Topamax

The prescription medication Topamax is a topiramate drug. The drug is an anti-convulsant medicine that was approved for use by itself or in conjunction with other medicines to treat epilepsy sufferers who have certain types of seizures. The drug has also been approved to prevent migraine headaches.

2011 Topamax Recall

As of April 14, 2011, Topamax was recalled. Its pharmaceutical manufacturer, Johnson & Johnson, recalled 57,000 bottles because of a complaint of foul odor. The recall involved at least two lots of 100-mg tablets distributed in the U.S. and Puerto Rico between approximately October 19, 2010 and December 28, 2010.

Health Concerns

The U.S. Food and Drug Administration (FDA) has warned healthcare professionals and consumers of risks of developing a cleft lip or cleft palate in babies born to women who took Topamax during their pregnancies. Other birth injuries might include conditions such as ASD; VSD; and defects of the heart, lungs, limbs or cranium. The FDA issued the warning because of clinical trial data on humans that showed a marked increase in the risk of cleft palates or lips.

The FDA classified Topamax in “Pregnancy Category D.” This classification signifies that there is evidence of human fetal risk based on clinical research or trials conducted. This classification means that potential benefits of using the prescription drug in pregnant patients could be acceptable in some cases, notwithstanding the health risks.

The FDA also recommended that women who are pregnant or of childbearing age should explore and discuss alternative treatments with their medical team before taking a topiramate drug like Topamax. Likewise, women who take Topamax should inform their doctors immediately if they are pregnant or plan to become so. A women should register with the North American Antiepileptic Drug Pregnancy Registry if taking the drug while pregnant.